US 11957704
Methods of treating metabolic disorders and cardiovascular disease with inhibin subunit beta E (INHBE) inhibitors
granted A61KA61K31/7088A61K31/7105
Quick answer
US patent 11957704 (Methods of treating metabolic disorders and cardiovascular disease with inhibin subunit beta E (INHBE) inhibitors) held by REGENERON PHARMACEUTICALS, INC. expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Apr 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/7088, A61K31/7105, A61K31/713, A61K38/22